Lanxess (ETR:LXS) has been assigned a €70.00 ($81.40) price objective by analysts at Deutsche Bank in a report issued on Friday. The brokerage presently has a “buy” rating on the stock. Deutsche Bank’s target price points to a potential upside of 54.53% from the stock’s current price.

A number of other research firms have also recently issued reports on LXS. Kepler Capital Markets set a €86.00 ($100.00) target price on Lanxess and gave the company a “buy” rating in a research note on Monday, November 12th. Goldman Sachs Group set a €67.00 ($77.91) target price on Lanxess and gave the company a “buy” rating in a research note on Tuesday, November 27th. UBS Group set a €78.00 ($90.70) target price on Lanxess and gave the company a “buy” rating in a research note on Wednesday, October 10th. Baader Bank set a €65.00 ($75.58) target price on Lanxess and gave the company a “sell” rating in a research note on Friday, September 21st. Finally, Credit Suisse Group set a €65.00 ($75.58) target price on Lanxess and gave the company a “neutral” rating in a research note on Tuesday, November 13th. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and ten have issued a buy rating to the company. The stock has an average rating of “Hold” and an average price target of €64.25 ($74.71).

LXS stock opened at €45.30 ($52.67) on Friday. Lanxess has a 1 year low of €59.89 ($69.64) and a 1 year high of €74.50 ($86.63).

Lanxess Company Profile

LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.

See Also: Debt-To-Equity Ratio

Analyst Recommendations for Lanxess (ETR:LXS)

Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.